These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23696737)

  • 1. Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
    Krey T; Meola A; Keck ZY; Damier-Piolle L; Foung SK; Rey FA
    PLoS Pathog; 2013; 9(5):e1003364. PubMed ID: 23696737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2.
    Vasiliauskaite I; Owsianka A; England P; Khan AG; Cole S; Bankwitz D; Foung SKH; Pietschmann T; Marcotrigiano J; Rey FA; Patel AH; Krey T
    mBio; 2017 May; 8(3):. PubMed ID: 28512091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.
    Keck ZY; Xia J; Wang Y; Wang W; Krey T; Prentoe J; Carlsen T; Li AY; Patel AH; Lemon SM; Bukh J; Rey FA; Foung SK
    PLoS Pathog; 2012; 8(4):e1002653. PubMed ID: 22511875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes.
    Gu J; Hardy J; Boo I; Vietheer P; McCaffrey K; Alhammad Y; Chopra A; Gaudieri S; Poumbourios P; Coulibaly F; Drummer HE
    J Virol; 2018 May; 92(9):. PubMed ID: 29467319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping a region of hepatitis C virus E2 that is responsible for escape from neutralizing antibodies and a core CD81-binding region that does not tolerate neutralization escape mutations.
    Keck ZY; Saha A; Xia J; Wang Y; Lau P; Krey T; Rey FA; Foung SK
    J Virol; 2011 Oct; 85(20):10451-63. PubMed ID: 21813602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for penetration of the glycan shield of hepatitis C virus E2 glycoprotein by a broadly neutralizing human antibody.
    Li Y; Pierce BG; Wang Q; Keck ZY; Fuerst TR; Foung SK; Mariuzza RA
    J Biol Chem; 2015 Apr; 290(16):10117-25. PubMed ID: 25737449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development.
    Ströh LJ; Krey T
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and Characterization of Monoclonal Antibodies against a Cyclic Variant of Hepatitis C Virus E2 Epitope 412-422.
    Sandomenico A; Leonardi A; Berisio R; Sanguigno L; Focà G; Focà A; Ruggiero A; Doti N; Muscariello L; Barone D; Farina C; Owsianka A; Vitagliano L; Patel AH; Ruvo M
    J Virol; 2016 Jan; 90(7):3745-59. PubMed ID: 26819303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
    Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ
    Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
    McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2.
    El Abd YS; Tabll AA; El Din NG; Hosny Ael-D; Moustafa RI; El-Shenawy R; Atef K; El-Awady MK
    Virol J; 2011 Aug; 8():391. PubMed ID: 21819575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody.
    Potter JA; Owsianka AM; Jeffery N; Matthews DJ; Keck ZY; Lau P; Foung SK; Taylor GL; Patel AH
    J Virol; 2012 Dec; 86(23):12923-32. PubMed ID: 22993159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region.
    Alhammad Y; Gu J; Boo I; Harrison D; McCaffrey K; Vietheer PT; Edwards S; Quinn C; Coulibaly F; Poumbourios P; Drummer HE
    J Virol; 2015 Dec; 89(24):12245-61. PubMed ID: 26378182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus.
    Deng L; Zhong L; Struble E; Duan H; Ma L; Harman C; Yan H; Virata ML; Zhao Z; Feinstone S; Alter H; Zhang P
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7418-22. PubMed ID: 23589879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies.
    Meola A; Tarr AW; England P; Meredith LW; McClure CP; Foung SK; McKeating JA; Ball JK; Rey FA; Krey T
    J Virol; 2015 Feb; 89(4):2170-81. PubMed ID: 25473061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of Hepatitis C Virus Envelope Glycoprotein E1 Antigenic Site 314-324 in Complex with Antibody IGH526.
    Kong L; Kadam RU; Giang E; Ruwona TB; Nieusma T; Culhane JC; Stanfield RL; Dawson PE; Wilson IA; Law M
    J Mol Biol; 2015 Aug; 427(16):2617-28. PubMed ID: 26135247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.
    Logan M; Law J; Wong JAJ; Hockman D; Landi A; Chen C; Crawford K; Kundu J; Baldwin L; Johnson J; Dahiya A; LaChance G; Marcotrigiano J; Law M; Foung S; Tyrrell L; Houghton M
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection.
    Rodrigo C; Walker MR; Leung P; Eltahla AA; Grebely J; Dore GJ; Applegate T; Page K; Dwivedi S; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Luciani F; Lloyd AR; Bull RA;
    Infect Genet Evol; 2017 Apr; 49():88-96. PubMed ID: 28065804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies.
    Pantua H; Diao J; Ultsch M; Hazen M; Mathieu M; McCutcheon K; Takeda K; Date S; Cheung TK; Phung Q; Hass P; Arnott D; Hongo JA; Matthews DJ; Brown A; Patel AH; Kelley RF; Eigenbrot C; Kapadia SB
    J Mol Biol; 2013 Jun; 425(11):1899-1914. PubMed ID: 23458406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conserved epitope III on hepatitis C virus E2 protein has alternate conformations facilitating cell binding or virus neutralization.
    Deng L; Hernandez N; Zhong L; Holcomb DD; Yan H; Virata ML; Tarafdar S; Xu Y; He Y; Struble E; Alter HJ; Zhang P
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34260404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.